AMR Clinical (AMR), an award-winning clinical research site company, today announced the appointment of Bernard Dyson as Chief Financial Officer. Dyson joins AMR’s executive leadership team to lead the company’s financial strategy and support its continued growth across therapeutic areas and geographies. He will serve as a key member of the executive leadership team, helping guide AMR Clinical through its next phase of expansion and innovation in clinical research.
